LevEllis expanded its executive and senior leadership team with the appointments of Renee Romero Pedroza as Chief Marketing Officer and Wendy Patrick as Vice President of Sales.
The appointments come as the biotechnology company scales PROVOQUE within professional aesthetics and develops its broader regenerative biology and skin longevity platform.
Pedroza will oversee U.S. and international commercial strategy.
Her responsibilities include professional and consumer marketing, e-commerce, business development, customer experience, product development, and provider advocacy.
Pedroza previously spent 14 years at ZO Skin Health, most recently serving as Senior Vice President of Global Marketing.
During her tenure, she helped grow ZO from an emerging professional skincare company into a larger global physician-dispensed skincare brand.
Patrick brings more than 20 years of experience across medical aesthetics, professional skincare, sales leadership, and strategic account development.
She most recently spent nearly six years at ALASTIN Skincare, a Galderma company.
Patrick’s responsibilities at LevEllis will include national sales strategy, revenue planning, field execution, strategic accounts, territory management, provider onboarding, and education.
PROVOQUE Facial Serum is the first commercial product built on LevEllis’ regenerative platform.
The company describes the platform as being based on a complete, skin-specific secretome derived from skin progenitor cells.
KEY QUOTES:
“What drew me to LevEllis was more than a new product. It was a fundamentally different approach to skin and Dr. Ellis’ vision for advancing regenerative skin health.”
Renee Romero Pedroza, CMO of LevEllis
“PROVOQUE is not a product you sell, it is one you teach, which requires a field team fluent enough in the biology to have the real conversation.”
Wendy Patrick, Vice President of Sales at LevEllis
“With Renee joining our C-Suite and Wendy leading our national sales organization, we’re putting the leadership in place to match the ambition of the science.”
Shannon Crothers, COO of LevEllis
